Does VINCRISTINE Cause Diffuse large b-cell lymphoma refractory? 331 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 331 reports of Diffuse large b-cell lymphoma refractory have been filed in association with VINCRISTINE (VinCRIStine Sulfate). This represents 0.5% of all adverse event reports for VINCRISTINE.
331
Reports of Diffuse large b-cell lymphoma refractory with VINCRISTINE
0.5%
of all VINCRISTINE reports
36
Deaths
51
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From VINCRISTINE?
Of the 331 reports, 36 (10.9%) resulted in death, 51 (15.4%) required hospitalization, and 7 (2.1%) were considered life-threatening.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VINCRISTINE. However, 331 reports have been filed with the FAERS database.
What Other Side Effects Does VINCRISTINE Cause?
Febrile neutropenia (8,676)
Off label use (6,562)
Disease progression (5,252)
Neutropenia (4,982)
Drug ineffective (4,084)
Pyrexia (3,460)
Product use in unapproved indication (3,073)
Thrombocytopenia (2,940)
Sepsis (2,791)
Anaemia (2,603)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
IFOSFAMIDE (154)
Which VINCRISTINE Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
VINCRISTINE vs VINDESINE
VINCRISTINE vs VINORELBINE
VINCRISTINE vs VINORELBINE\VINORELBINE
VINCRISTINE vs VIREAD
VINCRISTINE vs VISIPAQUE